Satraplatin in the treatment of hormone-refractory metastatic prostate cancer

Por Armstrong, Andrew J, George, Daniel J
Publicado em 2007

Tasquinimod in the treatment of castrate-resistant prostate cancer – current status and future prospects

Por Mehta, Amit R., Armstrong, Andrew J.
Publicado no Ther Adv Urol (2016)

Current Standard and Investigational Approaches to the Management of Hormone-Refractory Prostate Cancer

Por Mendiratta, Prateek, Armstrong, Andrew J, George, Daniel J
Publicado em 2007

Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T?

Por Bitting, Rhonda L., Armstrong, Andrew J., George, Daniel J.
Publicado em 2011

Epithelial–mesenchymal transition in prostate cancer: providing new targets for therapy

Por Armstrong, Andrew J, Freedland, Stephen J, Garcia-Blanco, Mariano
Publicado em 2011

Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease

Por Harrison, Michael R, Wong, Terence Z, Armstrong, Andrew J, George, Daniel J
Publicado em 2013

Using circulating tumor cells to inform on prostate cancer biology and clinical utility

Por Li, Jing, Gregory, Simon G., Garcia-Blanco, Mariano A., Armstrong, Andrew J.
Publicado no Crit Rev Clin Lab Sci (2015)

Biologic and Clinical Significance of Androgen Receptor Variants in Castration Resistant Prostate Cancer

Por Ware, Kathryn E, Garcia-Blanco, Mariano A, Armstrong, Andrew J, Dehm, Scott M.
Publicado no Endocr Relat Cancer (2014)

The role of epithelial plasticity in prostate cancer dissemination and treatment resistance

Por Bitting, Rhonda L., Schaeffer, Daneen, Somarelli, Jason A., Garcia-Blanco, Mariano A., Armstrong, Andrew J.
Publicado no Cancer Metastasis Rev (2014)

Evaluation of an Epithelial Plasticity (EP) Biomarker Panel in Men with Localized Prostate Cancer

Por Armstrong, Andrew J, Healy, Patrick, Halabi, Susan, Vollmer, Robin, Lark, Amy, Kemeny, Gabor, Ware, Kathryn, Freedland, Stephen J.
Publicado no Prostate Cancer Prostatic Dis (2015)

New and Emerging Therapies for Bone Metastases in Genitourinary Cancers

Por Saylor, Philip J., Armstrong, Andrew J., Fizazi, Karim, Freedland, Stephen, Saad, Fred, Smith, Matthew R., Tombal, Bertrand, Pienta, Kenneth
Publicado em 2012

The Association Between Radiographic Response and Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Receiving Chemotherapy

Por Sonpavde, Guru, Pond, Gregory R., Berry, William R., de Wit, Ronald, Eisenberger, Mario A., Tannock, Ian F., Armstrong, Andrew J.
Publicado em 2011

Development of a method to isolate circulating tumor cells using mesenchymal-based capture

Por Bitting, Rhonda L., Boominathan, Rengasamy, Rao, Chandra, Kemeny, Gabor, Foulk, Brad, Garcia-Blanco, Mariano A., Connelly, Mark, Armstrong, Andrew J.
Publicado em 2013

Prostate-Specific Antigen Changes As Surrogate for Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Second-Line Chemotherapy

Por Halabi, Susan, Armstrong, Andrew J., Sartor, Oliver, de Bono, Johann, Kaplan, Ellen, Lin, Chen-Yen, Solomon, Nicole C., Small, Eric J.
Publicado em 2013

Pharmacodynamic study of Disulfiram in Men with Non-metastatic Recurrent Prostate Cancer

Por Schweizer, Michael T., Lin, Jianqing, Blackford, Amanda, Bardia, Aditya, King, Serina, Armstrong, Andrew J., Rudek, Michelle A., Yegnasubramanian, Srinivasan, Carducci, Michael A.
Publicado em 2013

Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer

Por Armstrong, Andrew J., Eisenberger, Mario A., Halabi, Susan, Oudard, Stephane, Nanus, David M., Petrylak, Daniel P., Sartor, A. Oliver, Scher, Howard I.
Publicado em 2011

Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers

Por Armstrong, Andrew J., Marengo, Matthew S., Oltean, Sebastian, Kemeny, Gabor, Bitting, Rhonda L., Turnbull, James, Herold, Christina I., Marcom, Paul K., George, Daniel, Garcia-Blanco, Mariano A.
Publicado em 2011

Evaluating the Value of Number of Cycles of Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer

Por Pond, Gregory R., Armstrong, Andrew J., Wood, Brian A., Brookes, Melissa, Leopold, Lance, Berry, William R., de Wit, Ronald, Eisenberger, Mario A., Tannock, Ian F., Sonpavde, Guru
Publicado em 2011

Prognostic Model Predicting Metastatic Castration-Resistant Prostate Cancer Survival in Men Treated With Second-Line Chemotherapy

Por Halabi, Susan, Lin, Chen-Yen, Small, Eric J., Armstrong, Andrew J., Kaplan, Ellen B., Petrylak, Daniel, Sternberg, Cora N., Shen, Liji, Oudard, Stephane, de Bono, Johann, Sartor, Oliver
Publicado em 2013

Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells

Por Stoyanova, Tanya, Cooper, Aaron R., Drake, Justin M., Liu, Xian, Armstrong, Andrew J., Pienta, Kenneth J., Zhang, Hong, Kohn, Donald B., Huang, Jiaoti, Witte, Owen N., Goldstein, Andrew S.
Publicado em 2013